Anna Eshoo: “Collectively, I think your presence and your testimony is going to fuel our action.”

I find it hypocritical when I hear time and time and time again that plans are often blocked by PBMs from offering the lowest-priced generic.

I see, as I expressed to you when we spoke, a disconnect between CMS, the FDA, and the VA on new treatments for mild Alzheimer's.

This is, as you said and have said many times, this is a devastating disease, and I don't think this can be treated as 17 months of a little additional hope.

I rise, sadly, in opposition to this bill, H.R. 485. I support, and everyone here supports, banning quality-adjusted life years, also known as QALYs. It is a discriminatory metric that should not be used, and Democrats are the ones who…